The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, ...

More than 18 million people worldwide suffer from rheumatoid arthritis, including nearly 1.5 million Americans.

Treating high-risk people with a rheumatoid arthritis drug could help delay the condition's onset by up to 4 years, new research suggests.

The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, ...

PULLMAN, Wash. - The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of ...

South Korea's Hyundai ADM Bio plans to launch global clinical trials of its new drug, Penetrium, for rheumatoid arthritis and ...

You can reduce osteoporosis risk with RA and care for bone health through effective treatments, lifestyle changes, and proper ...

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

For at-risk patients, 1 year of treatment with abatacept appears to delay progression to rheumatoid arthritis for up to 4 years.

One-year treatment with abatacept delays progression to rheumatoid arthritis for up to 4 years among at-risk patients.

(By Dr. Lokesh A Veerappa) The risk of arthritis development for women increases because of their hormonal changes that occur during various stages of their life. The importance of preserving joint ...